Showing results (971-980 of 1,061) with videos related to
Sort By:
Pageof 107
Science (New York, N.Y.)|June 30, 2007
Crystal structure of inhibitor-bound human 5-lipoxygenase-activating proteinAndrew D Ferguson, Brian M McKeever, Shihua Xu, et al.The Prostate|March 10, 2001
Expression, purification, and characterization of active recombinant prostate-specific antigen in Pichia pastoris (yeast)L L Habeck, R M Belagaje, G W Becker, et al.Cell Death & Disease|July 14, 2023
Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodelingEmily R Quarato, Noah A Salama, Allison J Li, et al.Advanced Healthcare Materials|November 23, 2020
Amphiphilic Polyelectrolyte Graft Copolymers Enhance the Activity of Cyclic Dinucleotide STING AgonistsDinh Chuong Nguyen, Daniel Shae, Hayden M Pagendarm, et al.Biochemistry|May 19, 2004
Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificityGiovanna Scapin, Sangita B Patel, Christine Chung, et al.Journal of Medicinal Chemistry|May 4, 2001
Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigenR M Adlington, J E Baldwin, G W Becker, et al.Blood|December 6, 2015
Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndromeSophia R Balderman, Allison J Li, Corey M Hoffman, et al.ACS Nano|February 22, 2024
A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 AgonistsJessalyn J Baljon, Alexander J Kwiatkowski, Hayden M Pagendarm, et al.Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Ancient helium and tungsten isotopic signatures preserved in mantle domains least modified by crustal recyclingMatthew G Jackson, Janne Blichert-Toft, Saemundur A Halldórsson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical studyT M Behr, A L Salib, T Liersch, et al.Pageof 107